Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Epidermal growth factor receptor (EGFR) is a cell surface receptor tyrosine kinase.
• Ligand binding activates intracellular tyrosine kinase activity, initiating signaling pathways for cell differentiation and proliferation.
• Dysregulation of EGFR signaling is implicated in cancer development.

Purpose of the Study:

• To review the structure and function of EGFR.
• To explore the implications of EGFR mutations, overexpression, and ligand coexpression in cancer.
• To discuss the clinical aspects of targeting EGFR in cancer therapy.

Main Methods:

• Literature review of EGFR structure, function, and signaling pathways.
• Analysis of studies on EGFR gene amplification, mutations, and overexpression in various cancers.
• Examination of research on the development of the malignant phenotype driven by EGFR.
• Review of clinical trials and therapeutic strategies targeting EGFR.

Main Results:

• EGFR activation leads to downstream signaling cascades promoting cell growth, DNA synthesis, and oncogene expression.
• EGFR gene amplification, mutations, or overexpression are frequently observed in cancer cells.
• Targeting EGFR has emerged as a significant therapeutic strategy in oncology.

Conclusions:

• EGFR plays a critical role in normal cellular processes and its dysregulation contributes to oncogenesis.
• Understanding EGFR biology is crucial for developing effective cancer treatments.
• Targeted therapies against EGFR offer promising avenues for cancer management.